Brian M. Culley
Mr. Culley occupies the position of President, CEO & Independent Director at Lineage Cell Therapeutics, Inc.
He previously was Chief Executive Officer & Director at Savara, Inc. and Chief Executive Officer & Director at Mast Therapeutics, Inc. Director-Business Development & Marketing at iTherX Pharmaceuticals, Inc., Chief Executive Officer at Artemis Therapeutics, Inc. and Licensing & Marketing Associate at the University of California, Berkeley.
He received a graduate degree from the University of California, Santa Barbara, an undergraduate degree from Boston College and an MBA from Johnson Graduate School of Management.
See also: Lineage Cell Therapeutics - Lineage is a clinical-stage biotechnology company developing novel cell therapies
Brian M. Culley News
Longevity Technology interviews Lineage's CEO on the role of cell therapy in improving human longevity
Longevity Technology - 03-Aug-2023
Details magic of converting stem cells to any cell type and transplanting them to treat age-related conditionsRead more...
RPE-Cell therapy might potentially prevent blindness in dry AMD
Biospace - 14-Jun-2021
Lineage CEO says “it offers a whole new paradigm to treat the disease”Read more...
Super summary of 3rd Annual Longevity Therapeutics Summit
Lifespan.io (LEAF) - 16-Feb-2021
More and more companies making greater and greater progress - 2021 could be an exciting yearRead more...
Method of Generating Induced Pluripotent Stem Cells
Longevity Technology - 10-Dec-2019
New reprogramming technology could provide an alternate source of material needed for therapiesRead more...